UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Journal of thrombosis and haemostasis, 2015-05, Vol.13 (5), p.782-787

2015

Volltextzugriff (PDF)

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2010-02, Vol.8 (2), p.237-242

2010

Volltextzugriff (PDF)

The role of platelets in antiphospholipid syndrome

Platelets (Edinburgh), 2017-11, Vol.28 (8), p.762-766

2017

Volltextzugriff (PDF)

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Thrombosis research, 2018-12, Vol.172, p.172-178

2018

Volltextzugriff (PDF)

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Lupus, 2016-03, Vol.25 (3), p.301-306

2016

Volltextzugriff (PDF)

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2018-03, Vol.16 (3), p.529-532

2018

Volltextzugriff (PDF)

Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classification

Journal of thrombosis and haemostasis, 2008-10, Vol.6 (10), p.1693-1696

2008

Volltextzugriff (PDF)

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study

Clinica chimica acta, 2018-10, Vol.485, p.74-78

2018

Volltextzugriff (PDF)

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

Journal of thrombosis and haemostasis, 2013-08, Vol.11 (8), p.1527-1531

2013

Volltextzugriff (PDF)

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)

Lupus, 2019-12, Vol.28 (14), p.1663-1668

2019

Volltextzugriff (PDF)

Correct laboratory approach to APS diagnosis and monitoring

Autoimmunity reviews, 2013-06, Vol.12 (8), p.832-834

2013

Volltextzugriff (PDF)

APS - Diagnostics and challenges for the future

Autoimmunity reviews, 2016-11, Vol.15 (11), p.1031-1033

2016

Volltextzugriff (PDF)

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Thrombosis research, 2015-07, Vol.136 (1), p.161-163

2015

Volltextzugriff (PDF)

Laboratory testing for antiphospholipid syndrome

International journal of laboratory hematology, 2016-05, Vol.38 (S1), p.27-31

2016

Volltextzugriff (PDF)

Interpretation of laboratory data and need for reference laboratories

Lupus, 2012-06, Vol.21 (7), p.732-733

2012

Volltextzugriff (PDF)

Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism

Thrombosis research, 2008, Vol.122 (4), p.556-559

2008

Volltextzugriff (PDF)

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Thrombosis research, 2010-08, Vol.126 (2), p.150-153

2010

Volltextzugriff (PDF)

Antiphospholipid syndrome: critical analysis of the diagnostic path

Lupus, 2010-04, Vol.19 (4), p.428-431

2010

Volltextzugriff (PDF)

Secondary prevention in thrombotic antiphospholipid syndrome

Lupus, 2012-06, Vol.21 (7), p.734-735

2012

Volltextzugriff (PDF)

Circulating beta 2 glycoprotein I-IgG anti- beta 2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Lupus, 2012-06, Vol.21 (7), p.784-786

2012

Volltextzugriff (PDF)

Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Lupus, 2012-06, Vol.21 (7), p.784-786

2012

Volltextzugriff (PDF)

Antibodies to Domain I of β2 Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

Peripheral blood immune cells distribution in biopsy-proven myocarditis: etiology and prognostic correlates

European heart journal, 2024-10, Vol.45 (Supplement_1)

2024

Volltextzugriff (PDF)

Antibodies to Domain I of β 2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Thrombosis research, 2011-12, Vol.128 (6), p.583-586

2011

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Physics
(49)
Physical Sciences
(48)
Life Sciences & Biomedicine
(36)
Humans
(35)
Technology
(32)
Nuclear Experiment
(22)
Male
(18)
Exact Sciences And Technology
(17)
Female
(16)
Physics, Applied
(16)
Adult
(14)
Instruments & Instrumentation
(14)
Optics
(14)
Thrombosis
(13)
Antiphospholipid Syndrome
(12)
Antiphospholipid Syndrome - Immunology
(12)
Beta 2-Glycoprotein I - Immunology
(12)
Electric Dipoles
(12)
Ophthalmology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

The role of platelets in antiphospholipid syndrome

Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns

Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial

Thrombocytopenia in high‐risk patients with antiphospholipid syndrome

Influence of different IgG anticardiolipin antibody cut‐off values on antiphospholipid syndrome classification

Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study

Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile

An in vitro model to mimic the thrombotic occlusion of small vessels in catastrophic antiphospholipid syndrome (CAPS)

Correct laboratory approach to APS diagnosis and monitoring

APS - Diagnostics and challenges for the future

Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles

Laboratory testing for antiphospholipid syndrome

Interpretation of laboratory data and need for reference laboratories

Antibodies to oxidized LDL/β2-glycoprotein I in antiphospholipid syndrome patients with venous and arterial thromboembolism

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Antiphospholipid syndrome: critical analysis of the diagnostic path

Secondary prevention in thrombotic antiphospholipid syndrome

Circulating beta 2 glycoprotein I-IgG anti- beta 2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite Antiphospholipid Syndrome

Antibodies to Domain I of β2 Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Peripheral blood immune cells distribution in biopsy-proven myocarditis: etiology and prognostic correlates

Antibodies to Domain I of β 2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Suchergebnisse filtern